Amgen (AMGN) Change in Cash (2009 - 2026)

Amgen's Change in Cash history runs 18 years deep, the most recent figure standing at $2.9 billion for Q1 2026.

• In Q1 2026, Change in Cash rose 191.97% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $3.2 billion (up 459.47% YoY), while the FY2025 annual figure was -$2.8 billion, down 376.38% from the prior year.
• Change in Cash for Q1 2026 stood at $2.9 billion, up from -$316.0 million in the prior quarter.
• The five-year high for Change in Cash was $23.9 billion in Q1 2023, with the low at -$23.8 billion in Q4 2023.
• The 5-year median for Change in Cash is -$316.0 million (2025), against an average of $238.2 million.
• Peak annual rise in Change in Cash reached 1737.99% in 2023, while the deepest fall reached 1170.53% in 2023.
• Amgen's Change in Cash stood at -$1.9 billion in 2022, then slumped by 1170.53% to -$23.8 billion in 2023, then jumped by 112.45% to $3.0 billion in 2024, then slumped by 110.67% to -$316.0 million in 2025, then jumped by 1020.57% to $2.9 billion in 2026.
• Business Quant data shows AMGN's Change in Cash at $2.9 billion in Q1 2026, -$316.0 million in Q4 2025, and $1.4 billion in Q3 2025.